Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

151 Press Releases
DateTitleCompany
02 Feb 16 Ligand Enters Into OmniAb® Platform License Agreement with Tizona Therapeutics Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Jan 16 Ligand to Report Fourth Quarter and Full Year 2015 Results on February 10th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
13 Jan 16 Ligand Enters Into OmniAb® Platform License Agreement with Emergent BioSolutions Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
08 Dec 15 RODES Signs Exclusive Captisol® Licensing Agreement with Ligand Pharmaceuticals for Three Programs Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
18 Nov 15 Ligand Provides Highlights from Today’s Analyst Day Event Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
20 Oct 15 Ligand to Report Third Quarter Results on November 9th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
29 Sep 15 Ligand Expands Captisol License and Supply Agreements with SAGE Therapeutics to Include SAGE-689 Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
02 Sep 15 Revolade® Receives EU Approval as First-in-Class Therapy for Patients with Severe Aplastic Anemia Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
04 Aug 15 Matthew Korenberg to Join Ligand Pharmaceuticals as Chief Financial Officer Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
01 Aug 15 Ligand Enters into Commercial License and Supply Agreement with Sanofi for Captisol-enabled SAR-125844 Ligand Pharmaceuticals Incorporated,
Published by
PharmiWeb.com
30 Jul 15 Ligand Enters into Commercial License and Supply Agreement with Sanofi for Captisol-enabled SAR-125844 Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
25 Jul 15 Revolade® Recommended by CHMP for EU Approval to Treat Patients with Severe Aplastic Anemia, a Serious Blood Disorder Ligand Pharmaceuticals Incorporated,
Published by
PharmiWeb.com
24 Jul 15 Revolade® Recommended by CHMP for EU Approval to Treat Patients with Severe Aplastic Anemia, a Serious Blood Disorder Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
17 Jul 15 Ligand to Report Second Quarter Results on August 4th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
17 Jun 15 Ligand to Participate in Four Upcoming Investor Conferences Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
12 Jun 15 FDA Approves Promacta® for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
08 Jun 15 Ligand Announces Favorable Results From Phase 1b Trial With LGD-6972 in Type 2 Diabetes and Plans to Initiate a Phase 2 Trial Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
05 Jun 15 Ligand Announces New Time for June 7th Investor Presentation and Webcast at the American Diabetes Association 75th Scientific Sessions Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
02 Jun 15 Ligand Summarizes the Accounting Impact of the Viking Therapeutics Inc. IPO and Updates 2015 Financial Guidance Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
07 May 15 Ligand to Present Results of LGD-6972 Phase 1b Trial at American Diabetes Association 75th Scientific Sessions on June 7th and Host Investor Presentation Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
20 Apr 15 Ligand Partner TG Therapeutics Presents Positive Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research (AACR) Annual Meeting Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
05 May 15 Ligand Partner Viking Therapeutics Announces Closing of Initial Public Offering Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
03 Feb 15 Ligand Signs License Agreement with Sermonix for Lasofoxifene Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
11 May 15 Ligand Acquires Rights to More Than 15 Fully-Funded Development Programs from Selexis SA Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
06 Feb 15 Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission Seeking Additional Indication for Revolade® Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
03 Mar 15 Ligand to Present at the 27th Annual Roth Conference on March 9th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Apr 15 Ligand to Participate in Two Upcoming Investor Conferences Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
29 Apr 15 Ligand Partner Viking Therapeutics Announces Pricing of Initial Public Offering Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Apr 15 Ligand Names Melanie J. Herman Interim Chief Financial Officer Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Apr 15 Ligand to Report First Quarter Results on May 11th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.